entertainment -WSS

entertainment

author：explore 2025-09-07 11:13:27 - browse：83

Eli Lilly headquarters — Kristoffer Tripplaar/AP

Eventually, the luckiest companies get to deal with a very particular problem: what to do when their stock could be getting ahead of itself.

It’s a problem Eli Lilly got a little taste of Tuesday when it announced its full-year earnings. The drugmaker’s stock has more than doubled over the past 12 months due to the ever-increasing hopes for its GLP-1-based diabetes and weight loss drug, sold under the brand names Mounjaro and Zepbound. It was a big deal when Lilly became the first drug company ever to have a market value of $500 billion; it’s now sitting at a stunning $670 billion.

At first, the earnings report suggested the company had blasted through expectations again, announcing fourth-quarter 2023 sales of $9.35 billion, almost half a billion dollars above analysts’ expectations, and also announcing new data for Mounjaro in treating metabolic dysfunction-associated steatohepatitis (MASH), a form of liver disease previously called NASH. Initially, shares traded up 5%.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Activists slam private health insurers over coverage restrictions
Next article： Travis Kelce and the trap of celebrity vaccine endorsements

WSS

Sarepta Duchenne therapy fails to meet primary endpoint in trial

Readout LOUD podcast, live from the STAT Breakthrough Summit East

Coloradans with cystic fibrosis could lose access to Trikafta

Readout LOUD podcast, live from the STAT Breakthrough Summit East

After Sarepta trial failure, Duchenne families brace for more debate

Readout Newsletter: Illumina, CRISPR, Regeneron

entertainment

entertainment

Wikipedia

Malaria cases in Florida and Texas: Here’s what you need to know

'Patient friction coefficient' can gauge a clinical trial's patient burden

Tori Bowie and the unacceptable rates of Black maternal death

With Wegovy coverage, Medicare patients may face high costs

The Supreme Court will review a ruling striking down a domestic violence federal gun ban

Bill would allow buprenorphine prescription for addiction via telehealth

Dobbs anniversary: the lost opportunity of abortion as health care

Surgeons perform first xenotransplant using CRISPR'd pig kidney

How one medical school became remarkably diverse

Travis Kelce and the trap of celebrity vaccine endorsements

focus

Steward Health Care expansion into Malta flopped

With Wegovy coverage, Medicare patients may face high costs

Infant mortality in U.S. rose last year for first time in decades: CDC

Pfizer, Moderna say biotech, pharma drug development is a sprint

Bring on the sabbaticals for nurses

Brain injuries and the importance of a second opinion

entertainment

entertainment

focus

leisure time